| 1. |
- Begnini, Fabio, et al.
(författare)
-
Cell Permeability of Isomeric Macrocycles : Predictions and NMR Studies
- 2021
-
Ingår i: ACS Medicinal Chemistry Letters. - : American Chemical Society (ACS). - 1948-5875. ; 12:6, s. 983-990
-
Tidskriftsartikel (refereegranskat)abstract
- Conformation-dependent 3D descriptors have been shown to provide better predictions of the physicochemical properties of macrocycles than 2D descriptors. However, the computational identification of relevant conformations for macrocycles is nontrivial. Herein, we report that the Caco- 2 cell permeability difference between a pair of diastereomeric macrocycles correlated with their solvent accessible 3D polar surface area and radius of gyration. The descriptors were calculated from the macrocycles’ solution- phase conformational ensembles and independently from ensembles obtained by conformational sampling. Calculation of the two descriptors for three other stereo- and regioisomeric macrocycles also allowed the correct ranking of their cell permeability. Methods for conformational sampling may thus allow ranking of passive permeability for moderatelyflexible macrocycles, thereby contributing to the prioritization of macro- cycles for synthesis in lead optimization.
|
|
| 2. |
- Begnini, Fabio
(författare)
-
Discovery of Novel Macrocyclic Ligands for Difficult Targets : Applications to Natural Product Derived Keap1 Inhibitors
- 2021
-
Doktorsavhandling (övrigt vetenskapligt/konstnärligt)abstract
- The development of small-molecule ligands for biological targets that possess large, featureless or highly polar binding sites is a challenging task. This thesis is focused on a novel lead generation strategy to identify macrocyclic ligands for difficult-to-drug targets, as well as on the relationship between cell permeability and the conformations of macrocycles.A database of natural products was investigated to compile a set of macrocyclic cores to be used for in silico screening on difficult-to-drug targets. Docking of this set on Keap1, a target considered challenging due to its large and polar binding site, identified the core of the natural product cyclothialidine as a starting point for lead generation. Synthesis and evaluation of a small number of analogues provided a novel macrocyclic Keap1 inhibitor with potency in the low micromolar range that displayed cellular activity. Investigation of the structure-activity relationship of the lead inhibitor identified two positions amenable for optimization. In silico libraries were constructed at both positions using structure-based design to improve the affinity for Keap1. Subsequent synthesis of approximately 100 compounds led to an optimized lead series with potency in the low nanomolar range, providing a 100-fold improvement from the starting point. Additionally, the difference in passive cell permeability for a pair of diastereoisomeric macrocycles was rationalized on the basis of differences in their solution-phase conformations, that were determined by NMR spectroscopy. Moreover, for two sets of moderately flexible isomeric macrocycles, it was shown that the molecular descriptors predicted from conformational sampling correlated with cell permeability. This method may find use for prioritization of macrocycles prior to embarking on demanding synthetic routes.
|
|
| 3. |
- Begnini, Fabio, et al.
(författare)
-
Mining Natural Products for Macrocycles to Drug Difficult Targets
- 2021
-
Ingår i: Journal of Medicinal Chemistry. - : American Chemical Society (ACS). - 0022-2623 .- 1520-4804. ; 64:2, s. 1054-1072
-
Tidskriftsartikel (refereegranskat)abstract
- Lead generation for difficult-to-drug targets that have large, featureless, and highly lipophilic or highly polar and/or flexible binding sites is highly challenging. Here, we describe how cores of macrocyclic natural products can serve as a high-quality in silico screening library that provides leads for difficult-to-drug targets. Two iterative rounds of docking of a carefully selected set of natural-product-derived cores led to the discovery of an uncharged macrocyclic inhibitor of the Keap1-Nrf2 protein- protein interaction, a particularly challenging target due to its highly polar binding site. The inhibitor displays cellular efficacy and is well-positioned for further optimization based on the structure of its complex with Keapl and synthetic access. We believe that our work will spur interest in using macrocyclic cores for in silico-based lead generation and also inspire the design of future macrocycle screening collections.
|
|
